Skip to Main Content

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

June 16, 2020
Clinical Outcomes
Economic Outcomes
Article / Publication

Source: The Journal of Clinical Endocrinology & Metabolism

Key Takeaway: Nationwide reimbursement of real-time CGM improved HbA1c, fear of hypoglycemia, and QOL as well as economic indicators including work absenteeism and hospital admissions for acute diabetes complications.

The Value of rtCGM: Reduction in Hospitalizations and Work Absenteeism

 Pre-Reimbursement for rtCGMPost-Reimbursement for rtCGMP Value
 (n = 496)(n = 379) 
Patients with   
    Hospitalizations due to hypoglycemia and/or ketoacidosis77 (16%)14 (4%)<0.0005
    Hospitalizations due to hypoglycemia59 (11%)12 (3%)<0.0005
    Hospitalizations due to ketoacidosis23 (5%)4 (1%)0.092
    Work absenteesim*123 (25%)36 (9%)<0.0005
Days (per 100 patient years) of    
    Hospitalizations due to hypoglycemia and/or ketoacidosis53.517.8<0.0005
    Hospitalizations due to hypoglycemia38.512.50.001
    Hospitalizations due to ketoacidosis14.95.30.220
    Work absenteeism494.5233.80.001

Data are n (%).

*Work absenteeism of at least half a day. Patient-reported hospital admissions were validated by clinicians.

Reference: Charleer S, et al. Clin Endocrinol Metab. 2018;103(3):1224–1232

Reference: Charleer S, Mathieu C, Nobels F, et al. J Clin Endocrinol Metab. 2018;103(3):1224-1232.